Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer

Author： Simons W.R. Jones D. Buzdar A.

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.11, 2003-11, pp. : 2972-2987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bevacizumab: In First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma

By Frampton James E. Keating Gillian M.

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 113-120

Adis International

Access to resources Recommend Favorite

Lapatinib in Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer†: Profile Report

By Curran Monique P.

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 53-54

Adis International

Access to resources Recommend Favorite

Rituximab as First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma†: Profile Report

By Croxtall Jamie D.

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 329-331

Adis International

Access to resources Recommend Favorite

Oestrogen therapy for urinary incontinence in post-menopausal women

By Rojahn Ruth

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 458-459

Blackwell Publishing

Access to resources Recommend Favorite

Biological Therapy of Breast Cancer

By Park J.W. Tripathy D. Campbell M.J. Esserman L.J.

BioDrugs, Vol. 14, Iss. 4, 2000-10 ,pp. : 221-246

Adis International

Access to resources Recommend Favorite